Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.76% | 195.47 | 1.3% | $555.99m | |
| GILD | Gilead Sciences, Inc. | 0.24% | 66.52 | 0.9% | $368.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.79% | 107.40 | 2.0% | $321.44m | |
| ILMN | Illumina, Inc. | 1.14% | 300.91 | 3.5% | $301.00m | |
| BIIB | Biogen Inc. | 1.86% | 236.63 | 1.3% | $288.49m | |
| CELG | Celgene Corporation | -0.23% | 98.40 | 1.3% | $282.90m | |
| A | Agilent Technologies, Inc. | 0.43% | 77.90 | 1.6% | $193.04m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.25% | 86.00 | 14.7% | $180.31m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.44% | 174.94 | 1.9% | $173.66m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.90% | 281.62 | 2.6% | $171.53m | |
| EXAS | Exact Sciences Corporation | -1.82% | 106.71 | 24.1% | $132.03m | |
| ACAD | ACADIA Pharmaceuticals Inc. | 3.35% | 40.45 | 13.9% | $98.63m | |
| INCY | Incyte Corporation | 0.47% | 76.43 | 2.5% | $83.43m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.21% | 72.65 | 4.3% | $76.16m | |
| IONS | Ionis Pharmaceuticals, Inc. | -1.02% | 66.20 | 8.2% | $63.42m |
Company Profile
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.